Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 8/2023

30.08.2023 | Osteoporose | Leitthema

Trabecular Bone Score in der Rheumatologie

Gibt es einen Nutzen im Vergleich zur alleinigen Osteodensitometrie?

verfasst von: Zhivana Boyadzhieva, Andriko Palmowski, Frank Buttgereit, Paula Hoff

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Patient*innen mit entzündlich rheumatischen Erkrankungen weisen aufgrund des Entzündungspotenzials ihrer Erkrankung, aber auch wegen der oft notwendigen Glukokortikoidbehandlung ein erhöhtes Frakturrisiko auf. Die Abschätzung des Frakturrisikos erfolgt nach aktueller DVO(Dachverband Osteologie)-Leitlinie auch mittels „dual-energy X‑ray absorptiometry“, diese kann auch durch die Bestimmung des Trabecular Bone Score (TBS) ergänzt werden. Die Erhebung von TBS bringt zusätzliche Vorteile z. B. bei der Glukokortikoid-induzierten Osteoporose, aber auch bei Patient*innen mit osteoproliferativen Veränderungen an der Wirbelsäule (Spondylarthritiden) und optimiert somit im rheumatologischen Patientengut die Frakturrisikoabschätzung.
Literatur
1.
Zurück zum Zitat Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129PubMed Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129PubMed
2.
Zurück zum Zitat Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S et al (2017) Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 69(1):30–39PubMed Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S et al (2017) Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 69(1):30–39PubMed
3.
Zurück zum Zitat Cetin B, Cetin EA, Arikan H, Velioglu A, Alibaz-Oner F, Direskeneli H et al (2021) FRAX scores are increased in patients with ANCA-associated vasculitis. Int Urol Nephrol 53(11):2333–2339PubMed Cetin B, Cetin EA, Arikan H, Velioglu A, Alibaz-Oner F, Direskeneli H et al (2021) FRAX scores are increased in patients with ANCA-associated vasculitis. Int Urol Nephrol 53(11):2333–2339PubMed
4.
Zurück zum Zitat Chen J, Lei L, Pan J, Zhao C (2020) A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clin Rheumatol 39(4):1181–1189PubMed Chen J, Lei L, Pan J, Zhao C (2020) A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clin Rheumatol 39(4):1181–1189PubMed
5.
Zurück zum Zitat Molto A, Etcheto A, van der Heijde D, Landewe R, van den Bosch F, Bautista Molano W et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016–1023PubMed Molto A, Etcheto A, van der Heijde D, Landewe R, van den Bosch F, Bautista Molano W et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016–1023PubMed
6.
Zurück zum Zitat Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T et al (2018) Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med 16(1):4PubMedPubMedCentral Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T et al (2018) Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med 16(1):4PubMedPubMedCentral
7.
Zurück zum Zitat Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y et al (2016) Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int 27(4):1413–1423PubMed Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y et al (2016) Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int 27(4):1413–1423PubMed
8.
Zurück zum Zitat Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983PubMed Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983PubMed
10.
Zurück zum Zitat World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group
11.
Zurück zum Zitat Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the national bone health alliance working group. Osteoporos Int 25(5):1439–1443PubMedPubMedCentral Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the national bone health alliance working group. Osteoporos Int 25(5):1439–1443PubMedPubMedCentral
13.
Zurück zum Zitat Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A et al (2019) Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34(4):632–642PubMed Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A et al (2019) Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34(4):632–642PubMed
14.
Zurück zum Zitat Black DM, Bauer DC, Vittinghoff E, Lui LY, Grauer A, Marin F et al (2020) Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials. Lancet Diabetes Endocrinol 8(8):672–682PubMed Black DM, Bauer DC, Vittinghoff E, Lui LY, Grauer A, Marin F et al (2020) Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials. Lancet Diabetes Endocrinol 8(8):672–682PubMed
15.
Zurück zum Zitat Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C et al (2015) Trabecular Bone Score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224PubMedPubMedCentral Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C et al (2015) Trabecular Bone Score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224PubMedPubMedCentral
16.
Zurück zum Zitat Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96(45):e8661PubMed Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96(45):e8661PubMed
17.
Zurück zum Zitat Hans D, Stenova E, Lamy O (2017) The Trabecular Bone Score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice. Curr Osteoporos Rep 15(6):521–531PubMed Hans D, Stenova E, Lamy O (2017) The Trabecular Bone Score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice. Curr Osteoporos Rep 15(6):521–531PubMed
18.
Zurück zum Zitat Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the manitoba study. J Bone Miner Res 26(11):2762–2769PubMed Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the manitoba study. J Bone Miner Res 26(11):2762–2769PubMed
19.
Zurück zum Zitat McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31(5):940–948PubMed McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31(5):940–948PubMed
20.
Zurück zum Zitat Ruaro B, Casabella A, Paolino S, Alessandri E, Patane M, Gotelli E et al (2020) Trabecular bone score and bone quality in systemic lupus erythematosus patients. Front Med (Lausanne) 7:574842PubMed Ruaro B, Casabella A, Paolino S, Alessandri E, Patane M, Gotelli E et al (2020) Trabecular bone score and bone quality in systemic lupus erythematosus patients. Front Med (Lausanne) 7:574842PubMed
21.
Zurück zum Zitat Kim D, Cho SK, Kim JY, Choi YY, Sung YK (2016) Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol 26(4):540–545PubMed Kim D, Cho SK, Kim JY, Choi YY, Sung YK (2016) Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol 26(4):540–545PubMed
22.
Zurück zum Zitat Buehring B, Thomas J, Wittkamper T, Baraliakos X, Braun J (2020) Evaluation of the Trabecular Bone Score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol 79(10):1067–1074PubMedPubMedCentral Buehring B, Thomas J, Wittkamper T, Baraliakos X, Braun J (2020) Evaluation of the Trabecular Bone Score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol 79(10):1067–1074PubMedPubMedCentral
23.
Zurück zum Zitat Senn C, Gunther B, Popp AW, Perrelet R, Hans D, Lippuner K (2014) Comparative effects of teriparatide and ibandronate on spine Bone Mineral Density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporos Int 25(7):1945–1951PubMed Senn C, Gunther B, Popp AW, Perrelet R, Hans D, Lippuner K (2014) Comparative effects of teriparatide and ibandronate on spine Bone Mineral Density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporos Int 25(7):1945–1951PubMed
24.
Zurück zum Zitat Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES et al (2016) Trabecular bone score in patients with chronic glucocorticoid therapy-induced osteoporosis treated with alendronate or teriparatide. Arthritis Rheumatol 68(9):2122–2128PubMed Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES et al (2016) Trabecular bone score in patients with chronic glucocorticoid therapy-induced osteoporosis treated with alendronate or teriparatide. Arthritis Rheumatol 68(9):2122–2128PubMed
25.
Zurück zum Zitat Di Gregorio S, Del Rio L, Rodriguez-Tolra J, Bonel E, Garcia M, Winzenrieth R (2015) Comparison between different bone treatments on areal Bone Mineral Density (aBMD) and bone microarchitectural texture as assessed by the Trabecular Bone Score (TBS). Bone 75:138–143PubMed Di Gregorio S, Del Rio L, Rodriguez-Tolra J, Bonel E, Garcia M, Winzenrieth R (2015) Comparison between different bone treatments on areal Bone Mineral Density (aBMD) and bone microarchitectural texture as assessed by the Trabecular Bone Score (TBS). Bone 75:138–143PubMed
26.
Zurück zum Zitat Shin YH, Gong HS, Lee KJ, Baek GH (2019) Older Age and higher body mass index are associated with a more degraded trabecular bone score compared to bone mineral density. J Clin Densitom 22(2):266–271PubMed Shin YH, Gong HS, Lee KJ, Baek GH (2019) Older Age and higher body mass index are associated with a more degraded trabecular bone score compared to bone mineral density. J Clin Densitom 22(2):266–271PubMed
27.
Zurück zum Zitat Kong SH, Hong N, Kim JW, Kim DY, Kim JH (2021) Application of the trabecular bone score in clinical practice. J Bone Metab 28(2):101–113PubMedPubMedCentral Kong SH, Hong N, Kim JW, Kim DY, Kim JH (2021) Application of the trabecular bone score in clinical practice. J Bone Metab 28(2):101–113PubMedPubMedCentral
28.
Zurück zum Zitat Langsetmo L, Vo TN, Ensrud KE, Taylor BC, Cawthon PM, Schwartz AV et al (2016) The association between trabecular bone score and lumbar spine volumetric BMD is attenuated among older men with high body mass index. J Bone Miner Res 31(10):1820–1826PubMed Langsetmo L, Vo TN, Ensrud KE, Taylor BC, Cawthon PM, Schwartz AV et al (2016) The association between trabecular bone score and lumbar spine volumetric BMD is attenuated among older men with high body mass index. J Bone Miner Res 31(10):1820–1826PubMed
29.
Zurück zum Zitat Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR et al (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22(4):453–471PubMed Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR et al (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22(4):453–471PubMed
30.
Zurück zum Zitat Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom 18(3):309–330PubMed Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom 18(3):309–330PubMed
31.
Zurück zum Zitat Fuentes AV, Pineda MD, Venkata KCN (2018) Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy 6(2):43PubMedPubMedCentral Fuentes AV, Pineda MD, Venkata KCN (2018) Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy 6(2):43PubMedPubMedCentral
32.
Zurück zum Zitat Buckley L, Humphrey MB (2018) Glucocorticoid-induced osteoporosis. N Engl J Med 379(26):2547–2556PubMed Buckley L, Humphrey MB (2018) Glucocorticoid-induced osteoporosis. N Engl J Med 379(26):2547–2556PubMed
33.
Zurück zum Zitat Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131–R151PubMedPubMedCentral Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131–R151PubMedPubMedCentral
34.
Zurück zum Zitat Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–3229PubMed Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–3229PubMed
35.
Zurück zum Zitat Ito M (2014) Glucocorticoid and bone. Structural variations in steroid-induced osteoporosis. Clin Calcium 24(9):1343–1350PubMed Ito M (2014) Glucocorticoid and bone. Structural variations in steroid-induced osteoporosis. Clin Calcium 24(9):1343–1350PubMed
36.
Zurück zum Zitat Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150(12):2545–2548PubMed Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150(12):2545–2548PubMed
37.
Zurück zum Zitat Xue Y, Baker AL, Nader S, Orlander P, Sanchez AJ, Kellam J et al (2018) Lumbar spine Trabecular Bone Score (TBS) reflects diminished bone quality in patients with diabetes mellitus and oral glucocorticoid therapy. J Clin Densitom 21(2):185–192PubMed Xue Y, Baker AL, Nader S, Orlander P, Sanchez AJ, Kellam J et al (2018) Lumbar spine Trabecular Bone Score (TBS) reflects diminished bone quality in patients with diabetes mellitus and oral glucocorticoid therapy. J Clin Densitom 21(2):185–192PubMed
38.
Zurück zum Zitat Nahm FS (2022) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25–36PubMedPubMedCentral Nahm FS (2022) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25–36PubMedPubMedCentral
39.
Zurück zum Zitat Paggiosi MA, Peel NF, Eastell R (2015) The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int 26(6):1773–1780PubMed Paggiosi MA, Peel NF, Eastell R (2015) The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int 26(6):1773–1780PubMed
40.
Zurück zum Zitat Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC et al (2020) Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology 59(7):1574–1580PubMed Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC et al (2020) Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology 59(7):1574–1580PubMed
41.
Zurück zum Zitat Martineau P, Leslie WD, Johansson H, Harvey NC, McCloskey EV, Hans D et al (2018) In which patients does lumbar spine Trabecular Bone Score (TBS) have the largest effect? Bone 113:161–168PubMedPubMedCentral Martineau P, Leslie WD, Johansson H, Harvey NC, McCloskey EV, Hans D et al (2018) In which patients does lumbar spine Trabecular Bone Score (TBS) have the largest effect? Bone 113:161–168PubMedPubMedCentral
42.
Zurück zum Zitat Redondo L, Puigoriol E, Rodríguez JR, Peris P, Kanterewicz E (2018) Utilidad del Trabecular Bone Score en la valoración del riesgo de fractura osteoporótica. Rev Clin Esp 218(3):121–127PubMed Redondo L, Puigoriol E, Rodríguez JR, Peris P, Kanterewicz E (2018) Utilidad del Trabecular Bone Score en la valoración del riesgo de fractura osteoporótica. Rev Clin Esp 218(3):121–127PubMed
43.
Zurück zum Zitat Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E et al (2012) Osteoporosis in ankylosing spondylitis—Prevalence, risk factors and methods of assessment. Arthritis Res Ther 14(3):R108PubMedPubMedCentral Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E et al (2012) Osteoporosis in ankylosing spondylitis—Prevalence, risk factors and methods of assessment. Arthritis Res Ther 14(3):R108PubMedPubMedCentral
44.
Zurück zum Zitat Richards C, Hans D, Leslie WD (2020) Trabecular Bone Score (TBS) predicts fracture in ankylosing spondylitis: the manitoba BMD registry. J Clin Densitom 23(4):543–548PubMed Richards C, Hans D, Leslie WD (2020) Trabecular Bone Score (TBS) predicts fracture in ankylosing spondylitis: the manitoba BMD registry. J Clin Densitom 23(4):543–548PubMed
45.
Zurück zum Zitat Wildberger L, Boyadzhieva V, Hans D, Stoilov N, Rashkov R, Aubry-Rozier B (2017) Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis. Joint Bone Spine 84(4):463–466PubMed Wildberger L, Boyadzhieva V, Hans D, Stoilov N, Rashkov R, Aubry-Rozier B (2017) Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis. Joint Bone Spine 84(4):463–466PubMed
46.
Zurück zum Zitat Boussoualim K, Amouzougan A, Pallot-Prades B, Denarie D, Collet P, Marotte H et al (2018) Evaluation of bone quality with trabecular bone score in active spondyloarthritis. Joint Bone Spine 85(6):727–731PubMed Boussoualim K, Amouzougan A, Pallot-Prades B, Denarie D, Collet P, Marotte H et al (2018) Evaluation of bone quality with trabecular bone score in active spondyloarthritis. Joint Bone Spine 85(6):727–731PubMed
47.
Zurück zum Zitat Kang KY, Goo HY, Park SH, Hong YS (2018) Trabecular bone score as an assessment tool to identify the risk of osteoporosis in axial spondyloarthritis: a case-control study. Rheumatology (Oxford) 57(3):462–469PubMed Kang KY, Goo HY, Park SH, Hong YS (2018) Trabecular bone score as an assessment tool to identify the risk of osteoporosis in axial spondyloarthritis: a case-control study. Rheumatology (Oxford) 57(3):462–469PubMed
48.
Zurück zum Zitat Zuchowski P, Dura M, Jeka D, Waszczak-Jeka M (2022) The applicability of trabecular bone score for osteoporosis diagnosis in ankylosing spondylitis. Rheumatol Int 42(5):839–846PubMed Zuchowski P, Dura M, Jeka D, Waszczak-Jeka M (2022) The applicability of trabecular bone score for osteoporosis diagnosis in ankylosing spondylitis. Rheumatol Int 42(5):839–846PubMed
49.
Zurück zum Zitat Kang KY, Chung MK, Kim HN, Hong YS, Ju JH, Park SH (2018) Severity of sacroiliitis and erythrocyte sedimentation rate are associated with a low trabecular bone score in young male patients with ankylosing spondylitis. J Rheumatol 45(3):349–356PubMed Kang KY, Chung MK, Kim HN, Hong YS, Ju JH, Park SH (2018) Severity of sacroiliitis and erythrocyte sedimentation rate are associated with a low trabecular bone score in young male patients with ankylosing spondylitis. J Rheumatol 45(3):349–356PubMed
50.
Zurück zum Zitat Nam SW, Sung YK, Kim D, Cho SK, Song Y, Choi YY et al (2021) The usefulness of trabecular bone score in patients with ankylosing spondylitis. Korean J Intern Med 36(5):1211–1220PubMed Nam SW, Sung YK, Kim D, Cho SK, Song Y, Choi YY et al (2021) The usefulness of trabecular bone score in patients with ankylosing spondylitis. Korean J Intern Med 36(5):1211–1220PubMed
51.
Zurück zum Zitat Kang KY, Kim IJ, Park SH, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford) 57(6):1033–1040PubMed Kang KY, Kim IJ, Park SH, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford) 57(6):1033–1040PubMed
Metadaten
Titel
Trabecular Bone Score in der Rheumatologie
Gibt es einen Nutzen im Vergleich zur alleinigen Osteodensitometrie?
verfasst von
Zhivana Boyadzhieva
Andriko Palmowski
Frank Buttgereit
Paula Hoff
Publikationsdatum
30.08.2023
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 8/2023
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-023-01407-5

Weitere Artikel der Ausgabe 8/2023

Zeitschrift für Rheumatologie 8/2023 Zur Ausgabe

Mitteilungen der DGRh - Veranstaltungen der Rheumaakademie

Mitteilungen der DGRh - Veranstaltungen der Rheumaakademie

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.